All drugs.

Search drugs by brand or generic name, or refine the directory by prescription status, class, indication, manufacturer, and specialty.

Advertisement

Enter at least 3 characters to search the full directory.

Results

Showing 151–169 of 169 drugs · filtered

NINTEDANIB ESYLATE

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE ·+2
CIPLA USA, INC.

NINTEDANIB ESYLATE

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE ·+2
EDENBRIDGE/DEXC

NINTEDANIB ESYLATE

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE ·+2
SANDOZ

NINTEDANIB ESYLATE

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE ·+2
GSMS, INC.

NINTEDANIB ESYLATE

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE ·+2
EXELAN PHARMACE

IMATINIB MESYLATE

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA ·+11
SAFECOR HEALTH

BOSUTINIB

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · LYMPHOID BLAST PHASE PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOCYTIC LEUKEMIA ·+3
ALEMBIC PHARMAC

DASATINIB

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA ·+4
NORTHSTAR RX LL

BOSUTINIB

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · LYMPHOID BLAST PHASE PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOCYTIC LEUKEMIA ·+3
DR.REDDY'S LAB

CAVHANZA (nilotinib)

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · CHRONIC PHASE PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOCYTIC LEUKEMIA ·+1
CYCLE PHARMACEU

IMATINIB MESYLATE

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA ·+11
CIVICASCRIPT, L

JIDEYTRO (zidesamtinib)

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · ROS1 POSITIVE NON-SMALL CELL LUNG CANCER
NUVALENT, INC.

NINTEDANIB ESYLATE

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE ·+2
GLENMARK PHARMA

NINTEDANIB ESYLATE

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE ·+2
AVKARE

NINTEDANIB ESYLATE

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE ·+2
MACLEODS PHARMA

AFATINIB (afatinib dimaleate)

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · EPIDERMAL GROWTH FACTOR RECEPTOR POSITIVE NON-SMALL CELL LUNG CANCER ·+1
CAMBER PHARMACE

NINTEDANIB ESYLATE

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE ·+2
SANDOZ

DASATINIB

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA ·+4
NOVADOZ PHARMAC

ZEGFROVY (sunvozertinib)

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · NON-SMALL CELL LUNG CANCER WITH EGFR EXON 20 INSERTION MUTATION
DIZAL/ASTRAZENE